ACA

Copay accumulator plan designs: What life sciences manufacturers need to know heading into 2024

Copay accumulator plan designs: What life sciences manufacturers need to know heading into 2024

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, and Bill Sarraille, a partner with Sidley law, speak with Michael Harris, Mercalis’s VP of Patient Support Services Strategy, on the litigation brought by the HIV+Hepatitis Policy Institute against a federal government rule allowing insurers to not count copay assistance toward patient costs. The Court ruled in favor of patients but the government appealed and is refusing to enforce the Court’s ruling.

read more

North Carolina Blue Cross Blue Shield HIV Drug Tiers

Carl Schmid discusses NC Blue Cross Blue Shield’s decision to remove HIV drugs from the highest and costliest drug tiers following a discrimination complaint filed by the HIV+Hepatitis Policy Institute and NC AIDS Action Network.

read more

Pin It on Pinterest